Bioorganic and Medicinal Chemistry Letters p. 2473 - 2476 (2014)
Update date:2022-08-02
Topics:
Basham, Kaitlin J.
Bhonde, Vasudev R.
Kieffer, Collin
Mack, James B.C.
Hess, Matthew
Welm, Bryan E.
Looper, Ryan E.
Bis-aryloxadiazoles are common scaffolds in medicinal chemistry due to their wide range of biological activities. Previously, we identified a 1,2,4-bis-aryloxadiazole that blocks mammary branching morphogenesis through activation of the aryl hydrocarbon receptor (AHR). In addition to defects in mammary differentiation, AHR stimulation induces toxicity in many other tissues. We performed a structure activity relationship (SAR) study of 1,2,4-bis-aryloxadiazole to determine which moieties of the molecule are critical for AHR activation. We validated our results with a functional biological assay, using desmosome formation during mammary morphogenesis to indicate AHR activity. These findings will aid the design of oxadiazole derivative therapeutics with reduced off-target toxicity profiles.
View MoreZhengzhou Yuanli Biological Technology Co., Ltd.
Contact:+86-371-67897870/67897895
Address:No. 38, Qingyang Street, Zhengzhou, Henan, China
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
Contact:86-21-50966856
Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Suzhou SuKaiLu Chemical Technology Co., Ltd.
Contact:+86-512-62766020
Address:Floor 4, Building 1, Xinyi Pharmaceutical Valley Wisdom Industrial Park, 415 Changyang Street, Suzhou Industrial Park, Jiangsu Province
Doi:10.1016/j.bioorg.2020.104427
(2020)Doi:10.1016/j.carres.2014.04.004
(2014)Doi:10.1021/ol501175q
(2014)Doi:10.1055/s-0034-1379935
(2015)Doi:10.1080/15257779408012162
(1994)Doi:10.1016/0040-4020(94)00917-J
(1995)